Jacques Brouard
Expertise in
1
conditions

Jacques Brouard

CHU De Caen
Caen, FR 
Expertise in
1
conditions
CHU De Caen
Caen, FR 
OverviewLocationsClinical Research

Overview

Jacques Brouard practices in Caen, France. Mr. Brouard is highly rated in 1 condition, according to our data. His top areas of expertise are Bronchitis, Cerebral Hypoxia, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

CHU de Caen
Caen, 14000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Impact on Anti-infectious Treatments of the Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Community-acquired Pneumonia of Children at Pediatric Emergencies
Impact on Anti-infectious Treatments of the Early Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Community-acquired Pneumonia of Children at Pediatric Emergencies
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Other
Study Phase: Not Applicable
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients (ECENVIR Study)
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients (ECENVIR Study)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
Evaluation of an Antibiotic Treatment With 14 Days of Intravenous Tobramycin Versus the Same Antibiotic Associated With 5 Days of Intravenous Tobramycin Followed by Tobramycin Aerosol for 9 Days in Cystic Fibrosis.
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Drug
Study Drugs: Tobramycin, Nebcin
Study Phase: Phase 3
ANRS CO10 EPF - Cohort of HIV-infected Children
ANRS CO10 EPF - Cohort of HIV-infected Children
Enrollment Status: Completed
Publish Date: April 13, 2021
View 3 Less Clinical Trials

71 Total Publications

Phenotype-Genotype Correlations in ABCA3 Patients-The RespiRare Cohort.
Phenotype-Genotype Correlations in ABCA3 Patients-The RespiRare Cohort.
Journal: Pediatric pulmonology
Published: February 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Brouard's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile